Protective effects of erythropoietin against cuprizone-induced oxidative stress and demyelination in the mouse corpus callosum

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 237

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-20-8_007

تاریخ نمایه سازی: 28 مهر 1400

چکیده مقاله:

Objective(s): Increasing evidence in both experimental and clinical studies suggests that oxidative stress plays a major role in the pathogenesis of multiple sclerosis. The aim of the present work is to investigate the protective effects of erythropoietin against cuprizone-induced oxidative stress. Materials and Methods: Adult male C۵۷BL/۶J mice were fed a chow containing ۰.۲ % cuprizone for ۶ weeks. After ۳ weeks, mice were simultaneously treated with erythropoietin (۵,۰۰۰ IU/ kg body weight) by daily intraperitoneal injections. Results: Our results showed that cuprizone induced oxidative stress accompanied with down-regulation of subunits of the respiratory chain complex and demyelination of corpus callosum. Erythropoietin antagonized these effects. Biochemical analysis showed that oxidative stress induced by cuprizone was regulated by erythropoietin. Similarly, erythropoietin induced the expression of subunits of the respiratory chain complex over normal control values reflecting a mechanism to compensate cuprizone-mediated down-regulation of these genes. Conclusion: The data implicate that erythropoietin abolishes destructive cuprizone effects in the corpus callosum by decreasing oxidative stress and restoring mitochondrial respiratory enzyme activity.

نویسندگان

Iraj Ragerdi Kashani

Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Hossein Chavoshi

Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Parichehr Pasbakhsh

Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Mahmoud Hassani

Department of Medical Nanotechnologies, School of Advanced Technologies, Tehran University of Medical Sciences, Tehran, Iran

Ameneh Omidi

Department of Anatomical Sciences, Medical Sciences Faculty, Tarbiat Modares University, Tehran, Iran

Reza Mahmoudi

Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran

Cordian Beyer

Faculty of Medicine, Institute of Neuroanatomy, RWth Aachen University, Aachen, Germany

Adib Zendedel

Faculty of Medicine, Institute of Neuroanatomy, RWth Aachen University, Aachen, Germany

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • ۱.Xia Z, White CC, Owen EK, Von Korff A, Clarkson ...
  • ۲.Vakilzadeh G, Khodagholi F, Ghadiri T, Darvishi M, Ghaemi A, ...
  • ۳.Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodri-guez M, ...
  • ۴.Praet J, Guglielmetti C, Berneman Z, Van der Linden A, ...
  • ۵.Haider L. Inflammation, iron, energy failure, and oxidative stress in ...
  • ۶.Dadhania VP, Trivedi PP, Vikram A, Tripathi DN. Nutraceuticals against ...
  • ۷.Kasote DM, Hegde MV, Katyare SS. Mitochondrial dysfunction in psychiatric ...
  • ۸.Sinha K, Das J, Pal PB, Sil PC. Oxidative stress: ...
  • ۹.Carvalho AN, Lim JL, Nijland PG, Witte ME, Van Horssen ...
  • ۱۰.Liu J, Tian D, Murugan M, Eyo UB, Dreyfus CF, ...
  • ۱۱.Kaneko N, Kako E, Sawamoto K. Enhancement of ventricular-subventricular zone-derived ...
  • ۱۲.Csete M, Rodriguez L, Wilcox M, Chadalavada S. Erythro-poietin receptor ...
  • ۱۳.Yuan R, Maeda Y, Li W, Lu W, Cook S, ...
  • ۱۴.Najmi Varzaneh F, Najmi Varzaneh F, Azimi AR, Rezaei N, ...
  • ۱۵.Cervellini I, Ghezzi P, Mengozzi M. Therapeutic efficacy of erythropoietin ...
  • ۱۶.Cervellini I, Annenkov A, Brenton T, Chernajovsky Y, Ghezzi P, ...
  • ۱۷.Hagemeyer N, Boretius S, Ott C, Von Streitberg A, Welpinghus ...
  • ۱۸.Kashani IR, Rajabi Z, Akbari M, Hassanzadeh G, Mohseni A, ...
  • Suneetha A, Raja Rajeswari K. Role of dimethyl fumarate in ...
  • Lassmann H. What drives disease in multiple sclerosis: Inflammation or ...
  • ۲۱.Lassmann H. Pathology and disease mechanisms in different stages of ...
  • ۲۲.Torkildsen Ø, Brunborg LA, Thorsen F, Mørk SJ, Stangel M, ...
  • ۲۳.Lassmann H, Bradl M. Multiple sclerosis: experimental models and reality. ...
  • Tanaka T, Murakami K, Bando Y, Yoshida S. Minocycline reduces ...
  • ۲۵.Acs P, Kipp M, Norkute A, Johann S, Clarner T, ...
  • ۲۶.Ljubisavljevic S, Stojanovic I. Neuroinflammation and demyelination from the point ...
  • ۲۷.Kostic M, Zivkovic N, Stojanovic I. Multiple sclerosis and glutamate ...
  • ۲۸.Akisu M, Tuzun S, Arslanoglu S, Yalaz M, Kultursay N. ...
  • ۲۹.Bailey DM, Lundby C, Berg RM, Taudorf S, Rahmouni H, ...
  • ۳۰.Yildirim E, Ozisik K, Solaroglu I, Kaptanoglu E, Beskonakli E, ...
  • ۳۱.Akdemir Ozisik P, Oruckaptan H, Ozdemir Geyik P, Misirlioglu M, ...
  • ۳۲.Sims B, Clarke M, Njah W, Hopkins ES, Sontheimer H. ...
  • ۳۳.Hametner S, Wimmer I, Haider L, Pfeifenbring S, Brück W, ...
  • ۳۴.Rawji KS, Yong VW. The benefits and detriments of macrophages/microglia ...
  • ۳۵.Plenge U, Belhage B, Guadalupe-Grau A, Andersen PR, Lundby C, ...
  • نمایش کامل مراجع